Advertisement
Original report| Volume 3, ISSUE 2, P94-98, 1999

Download started.

Ok

Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil

Open ArchiveDOI:https://doi.org/10.1016/S1201-9712(99)90016-4
Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil
Previous ArticleEtiology of central nervous system infections in the Philippines and the role of serum C-reactive protein in excluding acute bacterial meningitis
Next ArticleImproved prognosis of Pseudomonas aeruginosca bacteremia in 127 consecutive neutropenic patients with hematologic malignancies
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Objectives: To determine the seroprevalence of herpes simplex virus type 2 (HSV-2) antibodies and the relation between the history of clinical herpes and the presence of type-specific HSV-2 antibodies in three different populations from the city of Campinas City, Brazil.
      Population and methods: One hundred and one college students, 96 patients with sexually transmitted diseases (STD), and 102 women at delivery were interviewed and blood samples were collected. Total HSV (HSV-1 and HSV-2) antibodies were screened by enzyme-linked immunosorbent assay (ELISA) and type-specific HSV 2 antibodies were detected by Western blot assay.
      Results: Herpes simplex virus antibodies were detected in 66.3% of the students, 97.1 % of the women at delivery, and 99.0% of the STD patients. Type-specific HSV-2 antibodies were detected in 6.9% of the students, 22.6% of the women at delivery, and in 53.1 % of the STD patients. History of genital herpes was reported by none of the students, by one of the women at delivery, and by 11 of 51 (21.6%) STD patients who were HSV-2 seropositive. Four of the 45 (8.9%) seronegative STD patients reported a history of genital herpes.
      Conclusion: The prevalence of HSV-2 infection in Campinas City can be significantly affected by the characteristics of the population studied, as was shown in previous studies. The sensitivity of the history of genital herpes was low in the present series, stressing that prophylactic measures for vertical and horizontal transmission of HSV-2 should not be based only on a positive history of genital ulcers.

      Keywords

      References

        • Nahmias A.J.
        • Roizman B.
        Infection with herpes simplex viruses 1 and 2.
        N Engl J Med. 1973; 289: 781-789
        • Catotti D.N.
        • Clarke P.
        • Catoe K.E.
        Herpes revisited.
        Sex Transm Dis. 1993; 20: 77-80
        • Mindel A.
        Long-term clinical and psychological management of genital herpes.
        J Med Virol. 1993; 1 (Suppl): 39-44
        • Mertz G.J.
        • Benedetti J.
        • Ashley R.
        • Selke A.S.
        • Corey L.
        Risk factor for the sexual transmission of genital herpes.
        Ann Intern Med. 1992; 116: 197-202
        • Bryson Y.
        • Dillon M.
        • Bernstein D.I.
        • Radolf J.
        • Zokowski P.
        • Garraty E.
        Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study.
        J Infect Dis. 1993; 167: 942-946
        • Prober C.G.
        • Hensleigh P.A.
        • Boucher F.D.
        • Yasukawa L.L.
        • Au D.S.
        • Arvin A.M.
        Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus.
        N Engl J Med. 1988; 318: 887-891
        • Frenkel L.M.
        • Garratty E.M.
        • Shen J.P.
        • Wheeler N.
        • Clark O.
        • Bryson Y.J.
        Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes.
        Ann Intern Med. 1993; 118: 414-418
        • Boggess K.A.
        • Watts D.H.
        • Hobson A.C.
        • Ashley R.L.
        • Brown Z.A.
        • Corey L.
        Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy.
        Am J Obstet Gynecol. 1997; 176: 443-451
        • Brown Z.A.
        • Vontver L.A.
        • Benedetti J.
        • et al.
        Effects on infants of a first episode of genital herpes during pregnancy.
        N Engl J Med. 1987; 317: 1246-1251
        • Corey L.
        • Whitley R.J.
        • Stone E.E.
        • Mohan K.
        Difference between herpes simplex virus type 1 and 2 neonatal encephalitis in neurological outcome.
        Lancet. 1988; 1: 1-4
        • Whitley R.J.
        • Corey L.
        • Arvin A.
        • et al.
        Changing presentation of herpes simplex virus infection in neonates.
        J Infect Dis. 1988; 158: 109-116
        • Brown Z.A.
        • Selke S.
        • Zeh J.
        • et al.
        The acquisition of herpes simplex virus during pregnancy.
        N Engl J Med. 1997; 337: 509-515
        • Dickerson M.C.
        • Hohnston J.
        • Delea T.E.
        • White A.
        • Andrews E.
        The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria.
        Sex Transm Dis. 1996; 23: 429-440
        • Coleman R.M.
        • Pereira L.
        • Bailey P.D.
        • Dondero D.
        • Wickliffe C.
        • Nahmias A.J.
        Determination of herpes simplex virus typespecific antibodies by enzyme-linked immunosorbent assay.
        J Clin Microbiol. 1983; 18: 287-291
        • Sullender W.M.
        • Yasukawa L.L.
        • Schwartz M.
        • et al.
        Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.
        J Infect Dis. 1988; 157: 164-171
        • Ashley R.L.
        • Militoni J.
        • Lee F.
        • Nahmias A.
        • Corey L.
        Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.
        J Clin Microbiol. 1988; 26: 662-667
        • Johnson R.E.
        • Nahmias A.
        • Magder L.S.
        • Lee F.K.
        • Brooks C.A.
        • Anowden C.B.
        A seroepidemiologic survey of the prevalence of herpes simplex type 2 infection in the United States.
        N Engl J Med. 1989; 321: 7-12
        • Fleming D.T.
        • McQuillan G.M.
        • Johnson R.E.
        • et al.
        Herpes simplex virus type 2 in the United States, 1976 to 1994.
        N Engl J Med. 1997; 337: 1105-1111
        • Cowan F.M.
        • Johnson A.M.
        • Ashley R.
        • Corey L.
        • Mindel A.
        Antibody to herpes simplex virus type 2, a serological marker of sexual lifestyle in populations.
        BMJ. 1994; 309: 1325-1329
        • Wald A.
        • Koutsky L.
        • Ashley R.L.
        • Corey L.
        Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections.
        Sex Transm Dis. 1997; 24: 149-155
        • Schomogyi M.
        • Wald A.
        • Corey L.
        Herpes simplex virus 2 infection. An emerging disease?.
        Infect Dis Clin North Am. 1998; 12: 47-61
        • Weimberg A.
        • Canto C.L.M.
        • Pannuti C.S.
        • Kwang W.N.
        • Garcia A.S.
        • Zugaib M.
        Herpes simplex type 2 infection in pregnancy: asymptomatic viral excretion at delivery and seroepidemiologic survey of two socioeconomically distinct populations in Sao Paulo, Brazil.
        Rev Inst Med Trop Sao Paulo. 1993; 35: 285-290
        • Christenson B.
        • Bottiger M.
        • Svensson A.
        • Jeansson S.
        A 15-year surveillance study of antibodies to herpes simplex virus type 1 and 2 in a cohort of young girls.
        J Infect Dis. 1992; 25: 147-154
        • Corey L.
        • Spear P.G.
        Infections with herpes simplex viruses.
        N Engl J Med. 1986; 314: 686-691
        • Koutsky L.A.
        • Ashley R.L.
        • Holmes K.K.
        • et al.
        The frequency of unrecognized type 2 herpes simplex virus infection among women.
        Sex Transm Dis. 1990; 17: 90-94
        • Gibson J.J.
        • Hornung C.A.
        • Alexander G.R.
        • Lee F.K.
        • Potts W.A.
        • Nahmias A.J.
        A cross-sectional study of herpes simplex virus type 1 and 2 in college students: occurrence and determinants of infection.
        J Infect Dis. 1990; 162: 306-312
        • Nahmias A.J.
        • Lee F.K.
        • Beckman-Nahmias S.
        Seroepidemiological and sociological patterns of herpes simplex virus infection in the world.
        Scand J Infect Dis. 1990; 69 (Suppl): 19-36
        • Rosa-Santos O.L.
        • Silva A.G.
        • Pereira Jr, A.C.
        Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
        Int J Dermatol. 1996; 35: 794-796
        • Gwanzura L.
        • McFarland W.
        • Alexander D.
        • Burke R.L.
        • Katzenstein D.
        Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe.
        J Infect Dis. 1998; 177: 481-484
        • Mulhall B.P.
        • Hart G.
        • Harcourt C.
        Sexually transmitted diseases in Australia: a decade of change. Epidemiology and surveillance.
        Ann Acad Med Singapore. 1995; 24: 569-578
        • Bassett I.
        • Donovan B.
        • Bodsworth N.J.
        • et al.
        Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre.
        Med J Aust. 1994; 160: 697-700
        • Corey L.
        • Adams H.G.
        • Brown Z.A.
        • Holmes K.K.
        Genital herpes simplex virus infections: clinical manifestations, course, and complications.
        Ann Intern Med. 1983; 98: 958-972

      Article info

      Publication history

      Accepted: July 22, 1998
      Received: April 20, 1998

      Identification

      DOI: https://doi.org/10.1016/S1201-9712(99)90016-4

      Copyright

      © 1999 Published by Elsevier Inc.

      User license

      Elsevier user license |
      How you can reuse Information Icon
      Elsevier user license

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Text & data mine
      • Translate the article

      Not Permitted

      • Reuse portions or extracts from the article in other works
      • Redistribute or republish the final article
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX